An overview of the intrathymic intricacies of T cell development

DK Shah, JC Zúñiga-Pflücker - The Journal of Immunology, 2014 - journals.aai.org
The generation of a functional and diverse repertoire of T cells occurs in the thymus from
precursors arriving from the bone marrow. In this article, we introduce the various stages of …

Hedgehog signaling in cancer: a prospective therapeutic target for eradicating cancer stem cells

IN Sari, LTH Phi, N Jun, YT Wijaya, S Lee, HY Kwon - Cells, 2018 - mdpi.com
The Hedgehog (Hh) pathway is a signaling cascade that plays a crucial role in many
fundamental processes, including embryonic development and tissue homeostasis …

Hedgehog-induced ZFYVE21 promotes chronic vascular inflammation by activating NLRP3 inflammasomes in T cells

B Jiang, S Wang, G Song, Q Jiang, M Fan, C Fang… - Science …, 2023 - science.org
The zinc finger protein ZFYVE21 is involved in immune signaling. Using humanized mouse
models, primary human cells, and patient samples, we identified a T cell–autonomous role …

CD3+ CD4− CD8−(double negative) T cells: saviours or villains of the immune response?

F D'Acquisto, T Crompton - Biochemical pharmacology, 2011 - Elsevier
Recent studies have shown that T cells are not just the latecomers in inflammation but might
also play a key role in the early phase of this response. In this context, a number of T cell …

Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells

Y Ding, S Shen, AC Lino, MA Curotto de Lafaille… - Nature medicine, 2008 - nature.com
Abstract β-catenin is a central molecule in the Wnt pathway. Expression of a stable form of β-
catenin on CD4+ CD25+ regulatory T (Treg) cells resulted in a marked enhancement of …

Cancer stem cells as targets for immunotherapy

AS Codd, T Kanaseki, T Torigo, Z Tabi - Immunology, 2018 - Wiley Online Library
Current cancer therapies target the bulk of the tumour, while a population of highly resistant
tumour cells may be able to repopulate the tumour and metastasize to new sites. Cancer …

Hedgehog pathway inhibitors against tumor microenvironment

S Gampala, JY Yang - Cells, 2021 - mdpi.com
Targeting the hedgehog (HH) pathway to treat aggressive cancers of the brain, breast,
pancreas, and prostate has been ongoing for decades. Gli gene amplifications have been …

Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma

A Otsuka, J Dreier, PF Cheng, M Nägeli… - Clinical Cancer …, 2015 - AACR
Abstract Purpose: Basal cell carcinomas (BCCs) are tumors ignored by immune
surveillance. Activated Hedgehog (Hh) signaling within primary cilia is a key driver in the …

Sonic hedgehog signalling in T-cell development and activation

T Crompton, SV Outram… - Nature Reviews …, 2007 - nature.com
The production of mature functional T cells in the thymus requires signals from the thymic
epithelium. Here, we review recent experiments showing that one way in which the …

The emerging roles of Hedgehog signaling in tumor immune microenvironment

J Wang, B Cui, X Li, X Zhao, T Huang, X Ding - Frontiers in Oncology, 2023 - frontiersin.org
The Hedgehog (Hh) signaling pathway is pervasively involved in human malignancies,
making it an effective target for cancer treatment for decades. In addition to its direct role in …